Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Development of Preterm Infants Born During the COVID-19 Pandemic

6. maj 2026 opdateret af: Joana Fernández Miró, Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Estudio Del Desarrollo de Los niños Prematuros Nacidos Durante la Pandemia Por el COVID-19

This study aims to evaluate differences in cognitive and psychomotor development among preterm infants (born before 34 weeks of gestation) delivered during the COVID-19 pandemic at Hospital de la Santa Creu i Sant Pau, compared with a control group of preterm infants born at the same hospital.

Studieoversigt

Undersøgelsestype

Observationel

Tilmelding (Anslået)

120

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Barn

Tager imod sunde frivillige

Ingen

Prøveudtagningsmetode

Ikke-sandsynlighedsprøve

Studiebefolkning

Preterm infants (born before 34 weeks of gestation), born from March 2020 to December 2021 (case group) and preterm infants (born before 34 weeks of gestation), born from January 2023 to December 2024 (control group). All those who have entered the NICU of Hospital de Sant Pau and follow up in external consultations.

Beskrivelse

Inclusion Criteria:

  • Preterm babies (<34 weeks of gestation) born between March 2020 and December 2021 for case group).
  • Preterm babies (<34 weeks of gestation) born between January 2023 to December 2024 (control group).
  • Babies who were admitted to the NICU of the Hospital de Sant Pau.
  • Babies who were followed up in External Consultations of the same hospital at least until their first year of age.

Exclusion Criteria:

  • Preterm infants ≥34 weeks or preterm born outside the periods described in the inclusion criteria.
  • Concurrent diagnosis of genetic pathology or major malformations.
  • Families who discontinued follow-up or did not attend scheduled appointments.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

Kohorter og interventioner

Gruppe / kohorte
Intervention / Behandling
Preterm babies born during the COVID-19 pandemic (2020-21)
Comparative and longitudinal study of development
Preterm babies born after the COVID-19 pandemic (2023-24)
Comparative and longitudinal study of development

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Bayley Scales Of Infant and Toddler Development
Tidsramme: All scores on this scale will be collected at the following ages for every child: - 3 months - 6 months - 12 months - 18 months - 24 months

It aims to evaluate the child's level of development in different areas. Through structured tasks and materials but in a playful format, it allows to obtain a global score of cognitive, motor and language development.

From the direct scores of the scale, it is possible to obtain scalar, composite and percentile scores. The scaled scores are calculated from the direct scores of each test. They have an average of 10 and a standard deviation of 3. They represent the child's performance in relation to children of his same age. The composite scores are typical scores obtained from scales with a mean of 100 and a standard deviation of 15. From these, the corresponding percentiles can be obtained in the tables included in the manual.

All scores on this scale will be collected at the following ages for every child: - 3 months - 6 months - 12 months - 18 months - 24 months
Wechsler Preschool and Primary Scale of Intelligence
Tidsramme: All scores on this scale will be collected at the following ages for every child: - 3 years old - 5 years old
It allows a complete measurement of the subject's cognitive abilities. Through structured tasks, standardized scores are obtained for the overall cognitive capacity, as well as for the verbal, manipulative, processing speed and general language indices. In this study we will collect typical scores, composites and percentiles of each of the subtests and indexes of the Scale. For this, based on the direct scores of each subtest, the typical scores are obtained whose mean is 10 and standard deviation 3. These scores allow inter-individual comparison. On the other hand, with several subtests the composite scores are formed, which correspond to the indices of the WPPSI-III (Verbal CI, Manipulative CI, Processing Speed, General Language and Total CI). The composite scores are converted to a scale of mean 100 and standard deviation of 15. In addition, the WPPSI-III offers percentiles for the scores of the subtests and for the indices.
All scores on this scale will be collected at the following ages for every child: - 3 years old - 5 years old

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Anslået)

1. maj 2026

Primær færdiggørelse (Anslået)

1. december 2029

Studieafslutning (Anslået)

1. december 2029

Datoer for studieregistrering

Først indsendt

5. maj 2026

Først indsendt, der opfyldte QC-kriterier

5. maj 2026

Først opslået (Faktiske)

6. maj 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

11. maj 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

6. maj 2026

Sidst verificeret

1. april 2026

Mere information

Begreber relateret til denne undersøgelse

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner